Medpace Holdings logo

Medpace Holdings Stock

StockStock
ISIN: US58506Q1094
Ticker: MEDP
US58506Q1094
MEDP

Price

Frequently asked questions

What is Medpace Holdings's market capitalization?

The market capitalization of Medpace Holdings is $9.89B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Medpace Holdings's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Medpace Holdings is 27.88. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Medpace Holdings?

Medpace Holdings's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $11.42. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Medpace Holdings's stock?

Currently, 7 analysts cover Medpace Holdings's stock, with a consensus target price of $447.43. Analyst ratings provide insights into the stock's expected performance.

What is Medpace Holdings's revenue over the trailing twelve months?

Over the trailing twelve months, Medpace Holdings reported a revenue of $2.07B.

What is the EBITDA for Medpace Holdings?

Medpace Holdings's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $437.53M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Medpace Holdings?

Medpace Holdings has a free cash flow of $535.65M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Medpace Holdings's stock?

The 5-year beta for Medpace Holdings is 1.36. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Medpace Holdings have, and what sector and industry does it belong to?

Medpace Holdings employs approximately 5,900 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Medpace Holdings's shares?

The free float of Medpace Holdings is 25.56M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$9.89B

5Y beta

 
1.36

EPS (TTM)

 
$11.42

Free Float

 
25.56M

P/E ratio (TTM)

 
27.88

Revenue (TTM)

 
$2.07B

EBITDA (TTM)

 
$437.53M

Free Cashflow (TTM)

 
$535.65M

Pricing

1D span
$311.13$320.48
52W span
$266.66$459.77

Analyst Ratings

The price target is $447.43 and the stock is covered by 7 analysts.

Buy

6

Hold

1

Sell

0

Information

Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.

5,900

Biotechnology & Drugs

Health Care

Identifier

ISIN

US58506Q1094

Primary Ticker

MEDP

Knockouts

Join the conversation